October 30, 2007
Miscarriage, Birth Defects Added to Cellcept Problems
Posted at October 30, 2007 3:04 PM in .
Cellcept, a drug used in heart, liver, and kidney transplant patients, has been linked to miscarriages and birth defects in female users of child-bearing age, according to the FDA. Cellcept, an immunosuppressant drug, already carries a black box warning is designed to keep the immune system from attacking the new organ. Roche, the manufacturer of Cellcept, has sent a letter to health officials, urging women to obtain a negative pregnancy test prior to beginning a regimen of Cellcept.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/420 .